4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-001104
President and CEO acquired 10,063 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-15 | Exercise or conversion : show line 1 in the form | +10,063 | $11.77 | $118,442 | 710,791 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-15 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −10,063 | 0 | D |
Loading xslF345X03/form4.xml…